Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Clinical Rheumatology

• Publication date

  2020-10-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10067-020-05456-yPMID 33078254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Description of Risk Factors for Non-alcoholic Fatty Liver Disease in the Southern Community Cohort Study: A Nested Case-Control Study

  2020cited by this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

  2020influential reference
• Rheumatologic Diseases and the Liver.

  2019cited by this paper
• "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?"

  2019cited by this paper
• Rheumatoid Arthritis.

  2019cited by this paper
• Rheumatoid Arthritis.

  2019cited by this paper
• Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long‐term follow‐up of predictors, surveillance, and outcome in clinical practice

  2019cited by this paper
• Clinical relevance of reporting fatty liver on ultrasound in asymptomatic patients during routine health checkups

  2018cited by this paper
• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

  2018cited by this paper
• Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment

  2018cited by this paper
• Hepatitis B virus infection and risk of non‐alcoholic fatty liver disease: A population‐based cohort study

  2018cited by this paper
• Clinical connection between rheumatoid arthritis and liver damage

  2018cited by this paper
• Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis

  2018cited by this paper
• Diagnosis and Management of Rheumatoid Arthritis: A Review

  2018cited by this paper
• Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease.

  2017cited by this paper
• Comment to: "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease".

  2017cited by this paper
• Role of folate in nonalcoholic fatty liver disease.

  2017cited by this paper
• Clinical epidemiology and disease burden of nonalcoholic fatty liver disease

  2017cited by this paper
• EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

  2016cited by this paper
• Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes

  2016cited by this paper
• Rheumatoid arthritis

  2016cited by this paper
• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  2016cited by this paper
• EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

  2016cited by this paper
• American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  2015cited by this paper
• Sleep and nighttime energy consumption in early childhood: a population‐based cohort study

  2015cited by this paper
• Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis

  2014cited by this paper
• A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples

  2014cited by this paper
• Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

  2013cited by this paper
• Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up.

  2012cited by this paper
• Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study.

  2012cited by this paper
• Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism.

  2010cited by this paper
• Non-invasive means of measuring hepatic fat content.

  2008cited by this paper
• Disruption of lipid metabolism in the liver of the pregnant rat fed folate-deficient and methyl donor-deficient diets

  2008cited by this paper
• Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adults

  2006cited by this paper
• Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study

  2005cited by this paper
• Hepatic manifestations of autoimmune rheumatic diseases

  2004cited by this paper
• Role of non‐alcoholic steatohepatitis in methotrexate‐induced liver injury

  2001cited by this paper
• [Rheumatoid arthritis].

  1983cited by this paper

• Prevalence of nonalcoholic fatty liver disease in rheumatoid arthritis: An updated systematic review and meta-analysis

  2025cites this paper
• Methotrexate and biological therapy are not associated with fatty liver in rheumatoid arthritis—a cross-sectional study

  2025cites this paper
• Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis

  2024cites this paper
• Increased NAFLD risk in newly diagnosed patients with RA during the first 4 years of follow-up: a nationwide, population-based cohort study

  2024cites this paper
• Use of Methotrexate for More Than 4 Years Is Not Associated with Liver Fibrosis in Rheumatoid Arthritis Patients

  2023cites this paper
• Antirheumatic drugs and the risk of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: A nationwide, population‐based cohort study

  2023cites this paper
• Prevalence of non-alcoholic fatty liver disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.

  2023cites this paper
• Non-metabolic causes of steatotic liver disease

  2023cites this paper
• This Letter to the Editor is in response to: Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology by Zamani M, etal.

  2023cites this paper
• Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort

  2022cites this paper
• Parkrun – More than a Run in the Park

  2021cites this paper
• The Effect of Hydroxychloroquine on Non-Alcoholic Fatty Liver Disease among Rheumatoid Arthritis Patients

  2021cites this paper
• World Journal of Hepatology

  year unknowncites this paper